Baseline relative eosinophil count as a predictive biomarker for ipilimumab treatment in advanced melanoma

As diverse therapeutic options are now available for advanced melanoma patients, predictive markers that may assist treatment decision are needed. A model based on baseline serum lactate dehydrogenase (LDH), peripheral blood relative lymphocyte counts (RLC) and eosinophil counts (REC) and pattern of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrucci, Pier Francesco, Gandini, Sara, Cocorocchio, Emilia, Pala, Laura, Baldini, Federica, Mosconi, Massimo, Antonini Cappellini, Gian Carlo, Albertazzi, Elena, Martinoli, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668095/
https://www.ncbi.nlm.nih.gov/pubmed/29108362
http://dx.doi.org/10.18632/oncotarget.19748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668095/
https://www.ncbi.nlm.nih.gov/pubmed/29108362
http://dx.doi.org/10.18632/oncotarget.19748

Ejemplares similares